Ignite Creation Date:
2024-05-06 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05122182
Status:
TERMINATED
Last Update Posted:
2023-09-15
First Post:
2021-11-14
Brief Title:
Controlled Trial of Angiotensin Receptor Blocker ARB Chemokine Receptor Type 2 CCR2 Antagonist for the Treatment of COVID-19
Sponsor:
Organization:
University of Sydney